Order Article Reprints

Hu W, Zhang L, Ferri-Borgogno S, Kwan S-Y, Lewis KE, Cun HT, Yeung T-L, Soliman PT, Tarapore RS, Allen JE, et al. Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436. Cancers. 2021; 13(4):623. https://doi.org/10.3390/cancers13040623

Hu, Wen, Li Zhang, Sammy Ferri-Borgogno, Suet-Ying Kwan, Kelsey E. Lewis, Han T. Cun, Tsz-Lun Yeung, Pamela T. Soliman, Rohinton S. Tarapore, Joshua E. Allen, and et al. 2021. "Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436" Cancers 13, no. 4: 623. https://doi.org/10.3390/cancers13040623

Hu, W., Zhang, L., Ferri-Borgogno, S., Kwan, S.-Y., Lewis, K. E., Cun, H. T., Yeung, T.-L., Soliman, P. T., Tarapore, R. S., Allen, J. E., Guan, X., Lu, K. H., Mok, S. C., & Au-Yeung, C.-L. (2021). Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436. Cancers, 13(4), 623. https://doi.org/10.3390/cancers13040623